Package 51662-1426-1

Brand: naloxone hydrochloride

Generic: naloxone hydrochloride
NDC Package

Package Facts

Identity

Package NDC 51662-1426-1
Digits Only 5166214261
Product NDC 51662-1426
Product ID 51662-1426_2b38388a-7ffd-a3f9-e063-6394a90a3566
Description

1 VIAL, GLASS in 1 CARTON (51662-1426-1) / 10 mL in 1 VIAL, GLASS

Marketing

Marketing Status
Marketed Since 2020-01-10
Brand naloxone hydrochloride
Generic naloxone hydrochloride
Sample Package No

Linked Drug Pages (1)

NALOXONE HYDROCHLORIDE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "2b38388a-7ffd-a3f9-e063-6394a90a3566", "openfda": {"upc": ["0370069072011"], "unii": ["F850569PQR"], "rxcui": ["1191222"], "spl_set_id": ["9bcff682-1196-7cef-e053-2a95a90aa954"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, GLASS in 1 CARTON (51662-1426-1)  / 10 mL in 1 VIAL, GLASS", "package_ndc": "51662-1426-1", "marketing_start_date": "20200110"}], "brand_name": "NALOXONE HYDROCHLORIDE", "product_id": "51662-1426_2b38388a-7ffd-a3f9-e063-6394a90a3566", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]"], "product_ndc": "51662-1426", "generic_name": "NALOXONE HYDROCHLORIDE", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "NALOXONE HYDROCHLORIDE", "active_ingredients": [{"name": "NALOXONE HYDROCHLORIDE", "strength": ".4 mg/mL"}], "application_number": "ANDA207634", "marketing_category": "ANDA", "marketing_start_date": "20200110", "listing_expiration_date": "20261231"}